| Literature DB >> 26763408 |
Andrew J Sawyer1, Themis R Kyriakides2.
Abstract
Extracellular matrix is composed of a complex array of molecules that together provide structural and functional support to cells. These properties are mainly mediated by the activity of collagenous and elastic fibers, proteoglycans, and proteins such as fibronectin and laminin. ECM composition is tissue-specific and could include matricellular proteins whose primary role is to modulate cell-matrix interactions. In adults, matricellular proteins are primarily expressed during injury, inflammation and disease. Particularly, they are closely associated with the progression and prognosis of cardiovascular and fibrotic diseases, and cancer. This review aims to provide an overview of the potential use of matricellular proteins in drug delivery including the generation of therapeutic agents based on the properties and structures of these proteins as well as their utility as biomarkers for specific diseases.Entities:
Keywords: Angiogenesis; Cell–matrix interactions; Extracellular matrix; Fibrosis; Matricellular
Mesh：
Substances：
Year: 2016 PMID： 26763408 PMCID： PMC4753140 DOI： 10.1016/j.addr.2015.12.016
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN： 0169-409X Impact factor: 15.470